India · Delayed Price · Currency is INR International Gemological Institute Earnings Call Transcripts
Fiscal Year 2025
-
Q4 and full year 2025 saw robust revenue and profit growth, with strong performance across natural and lab-grown diamond segments. Margins improved, cash reserves increased, and management expects to sustain growth in FY 2026 amid stable industry conditions.
-
Q3 and nine-month results showed robust double-digit growth in revenue, EBITDA, and volumes, with strong performance across all segments and geographies, especially India. Margins remained high, and the company is on track to meet or exceed full-year guidance despite macroeconomic and tariff headwinds.
-
Q2 and H1 CY25 saw strong revenue and EBITDA growth, driven by robust volume increases in both natural and lab-grown diamond certification. Margins remain healthy despite one-off AI investments, and the company maintains its 15%-20% revenue growth guidance for the year.
-
Q1 CY 2025 saw double-digit revenue and EBITDA growth, with strong volume gains and margin expansion. Lab-grown jewelry and international subsidiaries drove segmental growth, while pricing stabilized after last year's correction. Guidance remains robust for 2025.
Fiscal Year 2024
-
Surpassed INR 1,000 crore in consolidated revenue with 20% growth and strong margin expansion. Lab-grown diamond certification now exceeds 30% of volume, and recent acquisitions contribute 25% of group revenue. Management remains optimistic, targeting 15%-20% growth over five years.